Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07829016 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GLP-1 Impacts on Weight Management

Name: GLP-1 Impacts on Weight Management — clinical trial record (NCT07829016)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GLOW

StatusNot Yet Recruiting

PhaseNot specified

SponsorUniversity of California, San Francisco

Started2026-09-01

View on ClinicalTrials.gov ↗

University of California, San Francisco

637 trials monitored

See 53 trials at risk

Obesity

3,523 trials monitored

See 133 trials at risk

The goal of this observational study is to learn about the long-term effects of GLP-1RAs (Ozempic, Wegovy, Rybelsus, Mounjaro, or Zepbound) in adolescents and young adults aged 12-21 who will start taking this drug for weight management. The main question it aims to answer is: How does starting GLP-1RAs impact eating behaviors and mental health symptoms? Participants starting to take GLP-1RAs as part of their medical care for weight management will answer online survey questions about their experience taking the drug for 1 year.

Trial Details

NCT Number	NCT07829016
Lead Sponsor	University of California, San Francisco
Conditions	Weight Management, Disordered Eating Behaviors
Enrollment	100 participants
Start Date	2026-09-01
Primary Completion	2029-09-01 (estimated)
Study Completion	2029-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-28